The Rational Design of a Novel Potent Analogue of the 5′-AMP-Activated Protein Kinase Inhibitor Compound C with Improved Selectivity and Cellular Activity

Citation

Machrouhi, F., Ouhamou, N., Laderoute, K., Calaoagan, J., Bukhtiyarova, M., Ehrlich, P. J., & Klon, A. E. (2010). The rational design of a novel potent analogue of the 5′-AMP-activated protein kinase inhibitor compound C with improved selectivity and cellular activity. Bioorganic & medicinal chemistry letters, 20(22), 6394-6399.

Abstract

We have designed and synthesized analogues of compound C, a non-specific inhibitor of 5′-AMP-activated protein kinase (AMPK), using a computational fragment-based drug design (FBDD) approach. Synthesizing only twenty-seven analogues yielded a compound that was equipotent to compound C in the inhibition of the human AMPK (hAMPK) α2 subunit in the heterotrimeric complex in vitro, exhibited significantly improved selectivity against a subset of relevant kinases, and demonstrated enhanced cellular inhibition of AMPK.

↓ View online

Read more from SRI

  • surgeons around a surgical robot

    The SRI research behind today’s surgical robotics

    Intuitive’s da Vinci 5 system represents a major leap in robotic-assisted medicine. It all started at SRI, which continues to advance teleoperation technologies.

  • a collage of digital graphs

    A banner year for quantum

    SRI-managed QED-C’s annual report on quantum trends captures an industry accelerating rapidly from technical promise toward major global impact.

  • ICE Cube containing SRI’s aerogel experiment, photographed prior to launch. Source: Aerospace Applications North America

    An SRI carbon capture experiment launches into space

    By synthesizing carbon-absorbing aerogels in microgravity, SRI research will give us a rare glimpse into how these materials could be radically improved.